Application 200881

Type
ANDA
Sponsor
ACTAVIS ELIZABETH

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001GUANFACINE HYDROCHLORIDEGUANFACINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 1MG BASENoNo
002GUANFACINE HYDROCHLORIDEGUANFACINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 2MG BASENoNo
003GUANFACINE HYDROCHLORIDEGUANFACINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 3MG BASENoNo
004GUANFACINE HYDROCHLORIDEGUANFACINE HYDROCHLORIDETABLET, EXTENDED RELEASE;ORALEQ 4MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0228-2850guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2850guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2850guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2850guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2850guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2850guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2850guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2851guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2851guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2851guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2851guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2851guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2851guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2851guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2853guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2853guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2853guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2853guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2853guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2853guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2853guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2855guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2855guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2855guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2855guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2855guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2855guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
0228-2855guanfacineguanfacineActavis Pharma, Inc.ANDACurrent
42291-324guanfacineguanfacineAvKARE, Inc.ANDACurrent
42291-324guanfacineguanfacineAvKARE, Inc.ANDACurrent
42291-324guanfacineguanfacineAvKAREANDACurrent
42291-324guanfacineguanfacineAvKAREANDACurrent
42291-325guanfacineguanfacineAvKAREANDACurrent
42291-325guanfacineguanfacineAvKAREANDACurrent
42291-325guanfacineguanfacineAvKARE, Inc.ANDACurrent
42291-325guanfacineguanfacineAvKARE, Inc.ANDACurrent
42291-326guanfacineguanfacineAvKARE, Inc.ANDACurrent
42291-326guanfacineguanfacineAvKARE, Inc.ANDACurrent
42291-326guanfacineguanfacineAvKAREANDACurrent
42291-326guanfacineguanfacineAvKAREANDACurrent
42291-327guanfacineguanfacineAvKARE, Inc.ANDACurrent
42291-327guanfacineguanfacineAvKARE, Inc.ANDACurrent
42291-327guanfacineguanfacineAvKAREANDACurrent
42291-327guanfacineguanfacineAvKAREANDACurrent
63629-7138guanfacineguanfacineBryant Ranch PrepackANDACurrent
63629-7138guanfacineguanfacineBryant Ranch PrepackANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
32069ORIG2013-02-26